Purchases and Sales Made in Q1 2024 in Astria Therapeutics, Inc. (ATXS)
This table provides information about the institutional ownership of Astria Therapeutics, Inc. (ATXS) during Q1 2024. The information is specifically focused on institutions that hold shares of Astria Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2024
Q1 2024
|
Altium Capital Management LP
New York, NY |
SELL
|
- |
-587K- 80.48% |
$4.11M - $9.8M
|
143K
$867K
|
|
|
May 14, 2024
Q1 2024
|
Affinity Asset Advisors, LLC
New York, NY |
SELL
|
- |
-621K- 42.34% |
$4.34M - $10.4M
|
846K
$5.14M
|
|
|
May 13, 2024
Q1 2024
|
Stem Point Capital LP
New York, NY |
SELL
|
- |
-627K- 73.13% |
$4.38M - $10.5M
|
230K
$1.4M
|
|
|
May 15, 2024
Q1 2024
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-1.04M- 90.2% |
$7.26M - $17.3M
|
113K
$686K
|